3652 results for «329»
3652 results
Maintaining selective coronary access after TAVI and re-do TAVI procedures
28 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to understand the various challenges when trying to get coronary access after TAVI, learn different techniques and discuss the options for coronary access after re-do TAVI.
Optimising immediate and long-term outcomes after TAVI
29 Nov 2022 – From PCR London Valves 2022
This session addresses three important topics that impact post-procedural and long-term outcomes after performing TAVI: the impact of permanent pacemaker rates and paravalvular leak, the importance of neo-commissural alignment, and the role of cerebral embolic protection.
Valve-in-valve interventions
27 Nov 2022 – From PCR London Valves 2022
The 8 videos in this PCR LV 2022 session on ViV procedures will allow you to learn more about ultrasound imaging for BASILICA procedure optimization in ViV TAVI, or compare coronary access between 2 self-expandable TAVI in degenerated surgical bioprosthesis, and much more!
The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems
27 Nov 2022 – From PCR London Valves 2022
In this session from PCR London Valves 2022, discover the new Venus MedTech technology for tricuspid and pulmonary valve replacement, and a review of the clinical indications, selection criteria and procedural details.
Valve-in-valve TAVI: session 1
27 Nov 2022 – From PCR London Valves 2022
ViV TAVI in a patient with previous Bentall's operation, ViV for a failed surgical aortic bioprosthesis with a misaligned mitral bioprosthesis, TAVI for severe aortic regurgitation caused by infective endocarditis after homograft surgery, and much more in this PCR LV 2022 session about ViV TAVI!
Therapy of valvular heart diseases: a patient-centred innovation journey
27 Nov 2022 – From PCR London Valves 2022
Join a team of experts as they review together the complete spectrum of valvular heart disease and ways in which we can manage it using emerging novel technologies.
TAVI complications: Session 1
27 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of challenging TAVI complications cases: an annular rupture after TAVI in a bicuspid aortic valve, an outflow tract rupture during self-expandable transcatheter valve implantation, a periprocedural TAVI ischaemic stroke, and more!
Reinventing the treatment of patients with tricuspid valve disease
28 Nov 2022 – From PCR London Valves 2022
This innovative session takes you through the patient selection and anatomical characteristics when selecting amongst the different transcatheter options to treat tricuspid regurgitation, followed by a recorded demonstration using the PASCAL Precision repair system.
Rapid-fire abstracts: session 1
27 Nov 2022 – From PCR London Valves 2022
Watch this PCR LV 2022 session to get clinical outcomes after TAVR in obese and non-obese patients with small aortic annuli, to find out how non-calcific aortic valve tissue quantified from coronary CT angiography can predict one-year mortality post-TAVI, and even more!
BYPASS-CTCA: The value of computed tomography cardiac angiography in improving patient satisfaction and reducing contrast load, procedural duration and complications in patients who had previous CABG undergoing invasive coronary angiography
19 Sep 2022
Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.
It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.
Author
TRIGISTRY: Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE
31 Aug 2024
Alex Sticchi provides his take on the TRIGISTRY study presented by Julien Dreyfus at the ESC Congress 2024 in London.
Simultaneous publication in European Heart Journal, ehae578
Author
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
22 Mar 2022
Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022.
Author
